• Something wrong with this record ?

Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid

J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk

. 2010 ; 56 (3) : 394-403.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025453
003      
CZ-PrNML
005      
20130129170137.0
007      
ta
008      
120816s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.neuint.2009.11.011 $2 doi
035    __
$a (PubMed)19931336
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Folbergrová, Jaroslava, $d 1932- $7 jn20000400705 $u Institute of Physiology, Academy of Sciences of the Czech Republic, vvi, Vídenská 1083, 142 20 Prague 4, Czech Republic. folbergr@biomed.cas.cz
245    10
$a Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid / $c J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk
520    9_
$a Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.
650    _2
$a aldehydy $x metabolismus $7 D000447
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a mozková kůra $x metabolismus $x patologie $x patofyziologie $7 D002540
650    _2
$a konvulziva $x toxicita $7 D003292
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a down regulace $x účinky léků $x fyziologie $7 D015536
650    _2
$a respirační komplex I $x účinky léků $x metabolismus $7 D042967
650    _2
$a energetický metabolismus $x účinky léků $x fyziologie $7 D004734
650    _2
$a epilepsie $x metabolismus $x patofyziologie $7 D004827
650    _2
$a agonisté excitačních aminokyselin $x farmakologie $7 D018690
650    _2
$a scavengery volných radikálů $x farmakologie $7 D016166
650    _2
$a homocystein $x analogy a deriváty $x toxicita $7 D006710
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolické sítě a dráhy $x fyziologie $7 D053858
650    _2
$a mitochondrie $x účinky léků $x metabolismus $7 D008928
650    _2
$a mitochondriální nemoci $x chemicky indukované $x metabolismus $x patofyziologie $7 D028361
650    _2
$a oxidační stres $x účinky léků $x fyziologie $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a záchvaty $x chemicky indukované $x metabolismus $x patofyziologie $7 D012640
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a tyrosin $x analogy a deriváty $x metabolismus $7 D014443
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ješina, Pavel $7 xx0102694
700    1_
$a Haugvicová, Renata $7 xx0030584
700    1#
$a Lisý, Václav. $7 xx0181582
700    1_
$a Houštěk, Josef, $7 xx0030591 $d 1947-
773    0_
$w MED00003485 $t Neurochemistry international $x 1872-9754 $g Roč. 56, č. 3 (2010), s. 394-403
856    41
$u https://pubmed.ncbi.nlm.nih.gov/19931336 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130129170301 $b ABA008
999    __
$a ok $b bmc $g 947495 $s 782799
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 56 $c 3 $d 394-403 $i 1872-9754 $m Neurochemistry international $n Neurochem Int $x MED00003485
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...